ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #3,619Hybrid

Journal of Leukocyte Biology

Abbreviation (ISO):J. LEUKOCYTE BIOL
•
Identifier (ISSN):0741-5400(Print)/1938-3673(Online)
•
Publisher:John Wiley & Sons Inc.
Clarivate IF (2026)
3.4↑ +0.3
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Leukocyte Biology

WoS Q3
24684.2220184.0120193.7620204.9620216.0120225.520233.620243.120253.42026
Annual Impact Factor Metric
Current (2026):3.4
Scopus SJR & RankScopus Q2
1.203
#3,619

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
231

231 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
171articles/year
30.64% Gold OA•77.1% Original Research

Aims & Scope

JLB is a peer-reviewed, academic journal published by the Society for Leukocyte Biology for its members and the community of immunobiologists. The journal publishes papers devoted to the exploration of the cellular and molecular biology of granulocytes, mononuclear phagocytes, lymphocytes, NK cells, and other cells involved in host physiology and defense/resistance against disease. Since all cells in the body can directly or indirectly contribute to the maintenance of the integrity of the organism and restoration of homeostasis through repair, JLB also considers articles involving epithelial, endothelial, fibroblastic, neural, and other somatic cell types participating in host defense. Studies covering pathophysiology, cell development, differentiation and trafficking; fundamental, translational and clinical immunology, inflammation, extracellular mediators and effector molecules; receptors, signal transduction and genes are considered relevant. Research articles and reviews that provide a novel understanding in any of these fields are given priority as well as technical advances related to leukocyte research methods.

Topics Covered (Recognized by AI)
Biology97.1%Medicine85%Genetics84.2%Chemistry79.9%Biochemistry79.4%Immunology79.1%Internal medicine75.4%Cell biology56.1%Immune system49%Receptor40.5%In vitro39.9%Endocrinology32.8%Inflammation30.7%Molecular biology30.5%Gene29.8%Physics25%Organic chemistry23.9%Pathology22.3%Antigen22.2%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CELL BIOLOGY

Q3
Rank124/207
IndexSCIE
JCRSCIE2026

HEMATOLOGY

Q2
Rank34/103
IndexSCIE
JCRSCIE2026

IMMUNOLOGY

Q3
Rank93/183
IndexSCIE
JCISCIE2026

CELL BIOLOGY

Q3
Rank112/207
IndexSCIE
JCISCIE2026

HEMATOLOGY

Q2
Rank35/103
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q3
Rank105/183
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.4
Articles / Year124
Total Citations40
2025
IF3.1
Articles / Year191
Total Citations470
2024
IF3.6
Articles / Year264
Total Citations1,658
2023
IF5.5
Articles / Year182
Total Citations1,880
2022
IF6.011
Articles / Year171
Total Citations2,205

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,619Scopus Q2SCImago Profile
Scopus Coverage:1984-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q2
1.203

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
3.18

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,576 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,039
3-Year Documents578
Citable Documents543

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate48.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cell BiologyQ2
ImmunologyQ2
Immunology and AllergyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区CELL BIOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Leukocyte Biology (abbr: J. LEUKOCYTE BIOL, ISSN: 0741-5400) is a peer-reviewed international scholarly journal in the field of Medicine, published by John Wiley & Sons Inc. in United States. The periodical holds a Journal Impact Factor (JIF) of 3.40, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 1.203 (Q2), an H-index of 231.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 171 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,576 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
John Wiley & Sons Inc.
Publication Language
English
Frequency
Monthly
Indexing & Databases
SCIEScopusPubMed
Editorial Address
FEDERATION AMER SOC EXP BIOL, 9650 ROCKVILLE PIKE, BETHESDA, USA, MD, 20814-3998

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: ab45d9b8-6435-4366-bc99-aff664c2d1b5
Database Updated: 2026-10-01